Skip to main content

Table 3 Survival

From: Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction

 

Mean

1 year survival rate

5 year survival rate

All patients

35 months

70%

20%

Renal cell

38 months

72%

25%

Breast

44 months

87%

27%

Lung

22 months

67%

0%

Solitary bone late onset

49 months

91%

29%

All others

33 months

67%

18%

Revision surgery

53 months

  

No revision surgery

30 months